Similar articles

• Questioning the Associations of ω-3 Fatty Acid Supplement Use With Cardiovascular Disease Risks-Reply.

  Clarke RJ, Aung T, Armitage J. Clarke RJ, et al. JAMA Cardiol. 2018 Aug 1;3(8):781-782. doi: 10.1001/jamacardio.2018.1312. JAMA Cardiol. 2018. PMID: 29874365 No abstract available.
• Questioning the Associations of ω-3 Fatty Acid Supplement Use With Cardiovascular Disease Risks.

  Cicero AFG, Fogacci F, Borghi C. Cicero AFG, et al. JAMA Cardiol. 2018 Aug 1;3(8):780-781. doi: 10.1001/jamacardio.2018.1306. JAMA Cardiol. 2018. PMID: 29874376 No abstract available.
• Rebuttal to Aung et al, "Associations of Omega-3 Fatty Acid Supplement Use With Cardiovascular Disease Risks: Meta-analysis of 10 Trials Involving 77 917 Individuals".

  von Schacky C. von Schacky C. Altern Ther Health Med. 2018 Mar;24(2):8-9. Altern Ther Health Med. 2018. PMID: 29859508
• Omega-3 Fatty Acids and Primary and Secondary Prevention of Cardiovascular Disease.

  Cao Y, Lu L, Liang J, Liu M, Li X, Sun R, Zheng Y, Zhang P. Cao Y, et al. Cell Biochem Biophys. 2015 May;72(1):77-81. doi: 10.1007/s12013-014-0407-5. Cell Biochem Biophys. 2015. PMID: 25427890 Review.
• Omega-3 fatty acids: cardiovascular benefits, sources and sustainability.

  Lee JH, O'Keefe JH, Lavie CJ, Harris WS. Lee JH, et al. Nat Rev Cardiol. 2009 Dec;6(12):753-8. doi: 10.1038/nrcardio.2009.188. Epub 2009 Oct 27. Nat Rev Cardiol. 2009. PMID: 19859067 Review.